International Journal of Travel Medicine and Global Health

International Journal of Travel Medicine and Global Health

GSK3β-Knockdown Neural Progenitor Cells Promote Functional Recovery Following Traumatic Brain Injury in Mice

Document Type : Original Article

Authors
1 Department of Cellular and Molecular Biology,TeMS.C.,Islamic Azad University,Tehran,Iran
2 Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, United States
3 Department of Cellular and Molecular Biology, TeMS.C.,Islamic Azad University, Tehran, Iran
4 Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
10.30491/ijtmgh.2026.586914.1537
Abstract
Objective: Traumatic brain injury (TBI) leads to structural, cognitive, and behavioral deficits. Neural progenitor cells (NPCs) have gained attention due to their inherent plasticity and differentiation capacity. This study investigated whether GSK3β-knockdown NPCs enhance proliferation and differentiation in a mouse model of TBI.
Methods: TBI was induced in C57BL/6 mice using the weight drop method. NPCs were pretreated with lithium to suppress GSK3β expression, which was confirmed by Western blotting. Knockdown NPCs were transplanted intracerebroventricularly 24 hours after injury. Functional recovery was evaluated using the elevated plus maze (EPM) test. Brain tissue was examined by hematoxylin and eosin (H&E) staining for histopathological changes.
Results: EPM results showed a significant increase in velocity in TBI mice treated with NPCs (P < 0.01) or NPC-ND (P < 0.001) compared to the untreated TBI group. Histological analysis revealed fewer damaged cells, condensed neurons, and eosinophilic neurons in treated animals.
Conclusion: GSK3β-knockdown NPCs exert neuroprotective effects in TBI and may serve as promising candidates for regenerative medicine.
Keywords


Articles in Press, Accepted Manuscript
Available Online from 19 November 2026

  • Receive Date 16 June 2026
  • Revise Date 01 July 2026
  • Accept Date 03 July 2026